Update

Immunotherapy against Cancer
The podcast of the IOZK Foundation

Listen to the latest episode here >

In the IOZK Foundation's podcast, we provide comprehensive information about cancer in connection with individualised immunotherapy and new developments in research. Listen to our first episode about brain cancer now.

Beacon of hope
in cancer research:
Individualised
Immunotherapies

Personalised immunotherapies are a beacon of hope in cancer therapy. That is why, as part of our foundation work, we support translational medicine, which promptly implements research findings for cancer patients so that all options can be explored to improve their quality of life and chances of survival. In addition, we want to ensure that the topic of immuno-oncology receives more public attention through external communication.

The IOZK is a centre for translational medicine in the field of immunological oncology, where promising results from basic research are transferred into medical therapy. In 2015, the centre became the first institute in Europe to receive approval to manufacture the individual IO-VAC® vaccine for the treatment of tumours.

More about the IOZK >
‍

Individualised, targeted immunotherapy harnesses the body's own powers of self-healing in the fight against cancer. Side effects are rare and quality of life is high.

Discourse

Further information

The Consilium magazine and our foundation brochure provide further information on the subject and the scientific background of immunotherapy.

Consilium 2023

DOWNLOAD

Consilium 2021

DOWNLOAD

Info Stiftung

DOWNLOAD

Patienten-Information

DOWNLOAD